Create Account | Sign In: Author or Forum

Search Symptoms

CONFERENCE NEWS

Naloxone Products Stay Effective Long After Expiration Date

November 07, 2018. 7:00 PM CST. Narcan, Evzio chemically stable for at least 10 to 12 months after listed expiration dates Read article

OTHER CONFERENCE NEWS

ACR: Ixekizumab Tops Placebo in Axial Spondyloarthritis

October 22, 2018 Significant improvements for patients with prior inadequate response, intolerance to TNFi

ASA: Patients Assume Post-Op Opioids Are Best for Pain Relief

October 16, 2018 Ninety-four percent of patients who believe they will receive opioids think they will be effective

Lorcaserin Beneficial for Diabetes in Overweight, Obese

October 09, 2018 Lorcaserin reduces risk for diabetes for those with prediabetes, without diabetes; reduces HbA1c

Lixisenatide Cuts Kidney Damage in T2DM and Coronary Syndrome

October 05, 2018 Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria

Albiglutide Beats Placebo for Cardiovascular Events in T2DM

October 04, 2018 Despite having been withdrawn, albiglutide is superior to placebo for reducing cardiovascular events

Better Glycemic Control With Closed-Loop Insulin Delivery

October 03, 2018 Better glycemic control, reduced hypoglycemia risk for T1DM patients with suboptimal glycemic control

Nintedanib Plus Sildenafil No Better Than Nintedanib in IPF

September 28, 2018 No benefit with sildenafil in idiopathic pulmonary fibrosis with severe impairment in gas exchange

Partial Oral Abx Non-Inferior in Endocarditis on Left Side of Heart

August 30, 2018 Changing to oral antibiotics was non-inferior to continued intravenous antibiotic treatment

Experimental Drug Slows Mental Decline in Alzheimer’s Patients

July 27, 2018 However, the Phase 2 study of BAN2401 did not meet its primary end point

ASCO: Undertreatment Seen for Women With Head & Neck Cancer

June 07, 2018 Female patients are less likely to receive intensive chemo, radiation; increased risk for death from HNC

ASCO: Overall Survival Up for African-American Men With mCRPC

June 07, 2018 Improved survival versus Caucasian men treated with docetaxel/prednisone, DP-containing regimen

ASCO: Ovarian Suppression + Tamoxifen Ups Breast CA Survival

June 05, 2018 Increased disease-free, overall survival for premenopausal women with breast cancer

ASCO: mFOLFIRINOX Improves Survival in Pancreatic Cancer

June 04, 2018 And, pre-op chemoradiotherapy linked to longer overall survival than immediate surgery

ASCO: Endocrine Tx Noninferior for HR+, HER2− Breast Cancer

June 04, 2018 Similar efficacy for endocrine, chemoendocrine tx for women with midrange 21-gene recurrence score

ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer

June 04, 2018 Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival